292 related articles for article (PubMed ID: 33627623)
1. Neuregulin signaling mediates the acute and sustained antidepressant effects of subanesthetic ketamine.
Grieco SF; Qiao X; Johnston KG; Chen L; Nelson RR; Lai C; Holmes TC; Xu X
Transl Psychiatry; 2021 Feb; 11(1):144. PubMed ID: 33627623
[TBL] [Abstract][Full Text] [Related]
2. Subanesthetic Ketamine Reactivates Adult Cortical Plasticity to Restore Vision from Amblyopia.
Grieco SF; Qiao X; Zheng X; Liu Y; Chen L; Zhang H; Yu Z; Gavornik JP; Lai C; Gandhi SP; Holmes TC; Xu X
Curr Biol; 2020 Sep; 30(18):3591-3603.e8. PubMed ID: 32822611
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of neuregulin 1-ErbB4 signaling in parvalbumin interneurons in the rat brain may contribute to the antidepressant properties of ketamine.
Wang N; Zhang GF; Liu XY; Sun HL; Wang XM; Qiu LL; Yang C; Yang JJ
J Mol Neurosci; 2014; 54(2):211-8. PubMed ID: 24633675
[TBL] [Abstract][Full Text] [Related]
4. Neuregulin-1/ErbB4 Signaling Regulates Visual Cortical Plasticity.
Sun Y; Ikrar T; Davis MF; Gong N; Zheng X; Luo ZD; Lai C; Mei L; Holmes TC; Gandhi SP; Xu X
Neuron; 2016 Oct; 92(1):160-173. PubMed ID: 27641496
[TBL] [Abstract][Full Text] [Related]
5. Loss of phenotype of parvalbumin interneurons in rat prefrontal cortex is involved in antidepressant- and propsychotic-like behaviors following acute and repeated ketamine administration.
Zhou Z; Zhang G; Li X; Liu X; Wang N; Qiu L; Liu W; Zuo Z; Yang J
Mol Neurobiol; 2015 Apr; 51(2):808-19. PubMed ID: 24973145
[TBL] [Abstract][Full Text] [Related]
6. GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions.
Gerhard DM; Pothula S; Liu RJ; Wu M; Li XY; Girgenti MJ; Taylor SR; Duman CH; Delpire E; Picciotto M; Wohleb ES; Duman RS
J Clin Invest; 2020 Mar; 130(3):1336-1349. PubMed ID: 31743111
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Delivery of Ketamine Induces Cortical Disinhibition.
Qiao X; Grieco SF; Yu Z; Holmes TC; Xu X
eNeuro; 2024 Jan; 11(1):. PubMed ID: 38164560
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of ketamine action as an antidepressant.
Zanos P; Gould TD
Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
[TBL] [Abstract][Full Text] [Related]
9. Ketamine's rapid and sustained antidepressant effects are driven by distinct mechanisms.
Rawat R; Tunc-Ozcan E; Dunlop S; Tsai YH; Li F; Bertossi R; Peng CY; Kessler JA
Cell Mol Life Sci; 2024 Feb; 81(1):105. PubMed ID: 38413417
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway.
Jett JD; Boley AM; Girotti M; Shah A; Lodge DJ; Morilak DA
Psychopharmacology (Berl); 2015 Sep; 232(17):3123-33. PubMed ID: 25986748
[TBL] [Abstract][Full Text] [Related]
11. Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine.
Carreno FR; Donegan JJ; Boley AM; Shah A; DeGuzman M; Frazer A; Lodge DJ
Mol Psychiatry; 2016 Sep; 21(9):1298-308. PubMed ID: 26619811
[TBL] [Abstract][Full Text] [Related]
12. ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation.
Chen YJ; Zhang M; Yin DM; Wen L; Ting A; Wang P; Lu YS; Zhu XH; Li SJ; Wu CY; Wang XM; Lai C; Xiong WC; Mei L; Gao TM
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21818-23. PubMed ID: 21106764
[TBL] [Abstract][Full Text] [Related]
13. Sex Differences in the Temporal Neuromolecular and Synaptogenic Effects of the Rapid-acting Antidepressant Drug Ketamine in the Mouse Brain.
Thelen C; Flaherty E; Saurine J; Sens J; Mohamed S; Pitychoutis PM
Neuroscience; 2019 Feb; 398():182-192. PubMed ID: 30537521
[TBL] [Abstract][Full Text] [Related]
14. Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders.
Lewis V; Rodrigue B; Arsenault E; Zhang M; Taghavi-Abkuh FF; Silva WCC; Myers M; Matta-Camacho E; Aguilar-Valles A
J Neurochem; 2023 Jul; 166(1):10-23. PubMed ID: 35680556
[TBL] [Abstract][Full Text] [Related]
15. Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.
Kim JW; Monteggia LM
Behav Brain Res; 2020 Feb; 380():112378. PubMed ID: 31760154
[TBL] [Abstract][Full Text] [Related]
16. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.
Liu RJ; Fuchikami M; Dwyer JM; Lepack AE; Duman RS; Aghajanian GK
Neuropsychopharmacology; 2013 Oct; 38(11):2268-77. PubMed ID: 23680942
[TBL] [Abstract][Full Text] [Related]
17. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
[TBL] [Abstract][Full Text] [Related]
18. Neuregulin and ErbB expression is regulated by development and sensory experience in mouse visual cortex.
Grieco SF; Wang G; Mahapatra A; Lai C; Holmes TC; Xu X
J Comp Neurol; 2020 Feb; 528(3):419-432. PubMed ID: 31454079
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of neuregulin 1-ErbB4 signaling and antidepressant properties of ketamine: ErbB4 expressing pyramidal neurons may play a role.
Bernstein HG; Keilhoff G; Steiner J; Laube G; Bogerts B
J Mol Neurosci; 2015 Feb; 55(2):372-3. PubMed ID: 24874581
[TBL] [Abstract][Full Text] [Related]
20. A key requirement for synaptic Reelin signaling in ketamine-mediated behavioral and synaptic action.
Kim JW; Herz J; Kavalali ET; Monteggia LM
Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33975959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
